Detalles de la búsqueda
1.
Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.
Blood
; 131(13): 1456-1463, 2018 03 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29437590
2.
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial.
Eur J Cancer
; 158: 17-26, 2021 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638090
3.
Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial.
Eur J Cancer
; 87: 147-163, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29149761
4.
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.
J Clin Oncol
; 35(16): 1786-1794, 2017 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28291393
5.
A multinational, multi-tumour basket study in very rare cancer types: The European Organization for Research and Treatment of Cancer phase II 90101 'CREATE' trial.
Eur J Cancer
; 109: 192-195, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30655100
6.
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.
J Clin Oncol
; 32(12): 1188-94, 2014 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24637998
Resultados
1 -
6
de 6
1
Próxima >
>>